ALNFL — Nfl Biosciences SAS Share News
0.000.00%
Last trade - 00:00Brief: NFL Biosciences Receives Funding Of EUR 1.7 Mln From Bpifrance
Brief: NFL Biosciences Raises Over EUR 3 Million
Brief: NFL Biosciences/Themis Medicare: Partnership To Develop NFL-101, Drug Candidate For Smoking Cessation
Brief: NFL Biosciences Launches Phase 2/3 Clinical Trial For Smoking Cessation
Brief: NFL Biosciences Signs Production Agreement With Diverchim
Brief: French biopharmaceutical company NFL Biosciences SA raises 5 mln euros via Euronext IPO